Drugs News and Research

RSS

States target health insurers’ ‘prior authorization’ red tape

Christopher Marks noticed an immediate improvement when his doctor prescribed him the Type 2 diabetes medication Mounjaro last year.

12 Feb 2024

Stress driving substance use in American teens, study finds

A study in the Morbidity and Mortality Weekly Report reveals stress and experimentation as primary motivators for substance use among American adolescents, with significant implications for developing targeted interventions and educational programs.

11 Feb 2024

Drug repurposing study finds lonafarnib effective against RSV

A study in Nature Communications identifies lonafarnib from the ReFRAME drug-repurposing library as a potent inhibitor of the RSV fusion protein, showing promise in reducing RSV infection in vitro and in vivo.

11 Feb 2024

New study finds 4’-fluorouridine effective against avian influenza in vitro and in vivo

A PLOS Pathogens study reveals 4’-fluorouridine effectively combats avian influenza in vitro and in animal models, showing promise as a treatment that overcomes resistance and reduces disease severity without significant adverse effects.

11 Feb 2024

IPIAD augments standard therapy for pancreatic ductal adenocarcinoma

A new research perspective was published in Oncoscience (Volume 11) on February 7, 2024, entitled, "IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone."

9 Feb 2024

Reducing diabetes medication costs can be one step toward improving health outcomes

A new study led by researchers at the Harvard Pilgrim Health Care Institute has found that reducing out-of-pocket costs for patients with diabetes, especially those considered low income, can be one step toward improving health outcomes.

9 Feb 2024

Rucaparib and its major metabolite exhibit differential biological activity and synergy

Once they enter the body, drugs, apart from carrying out their therapeutic function, are biochemically transformed by the action of the metabolic machinery, a process that facilitates their expulsion.

9 Feb 2024

LSHTM researchers receive £2m funding to develop novel vaccines, diagnostics and therapeutics

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been awarded £2m funding through the UK Research and Innovation's (UKRI) Technology Missions Fund, to develop novel vaccines, diagnostics and therapeutics.

9 Feb 2024

AI tool maps protein function in tumors, paving way for personalized cancer treatment

Scientists have developed a new AI tool that maps the function of proteins in a cancerous tumor, enabling clinicians to decide how to target treatment in a more precise way.

9 Feb 2024

CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to US$1.8 million to biotechnology company, Visby Medical, to develop a portable rapid polymerase chain reaction (PCR) diagnostic to detect the presence of the pathogen that causes gonorrhea, Neisseria gonorrhoeae (NG), and its susceptibility to ciprofloxacin, a former frontline oral antibiotic that can no longer treat resistant NG.

9 Feb 2024

Men using erectile dysfunction drugs less likely to develop Alzheimer's disease

Drugs commonly used to treat erectile dysfunction may reduce the risk of Alzheimer's disease, finds a new study led by UCL researchers.

9 Feb 2024

New MRI method enables early detection and better monitoring of multiple sclerosis

Multiple sclerosis (MS) is a neurological disease that usually leads to permanent disabilities. It affects around 2.9 million people worldwide, and around 15,000 in Switzerland alone.

8 Feb 2024

Immune cells in overdrive: Study finds unbalanced response worsens lung infections

CD4+ T cells have been highlighted in the scientific literature for the important role they play in the immune response to lung infections.

8 Feb 2024

New drug targets key mechanism in ALS, protects motor neurons

A new pharmacological inhibitor can intervene in a central cell death mechanism that is responsible for the death of motor neurons and hence important for the progression of the motor neuron disease amyotrophic lateral sclerosis (ALS).

8 Feb 2024

Hope for relapsed myeloma: Preclinical and clinical evidence for ruxolitinib's efficacy

A new research perspective was published in Oncotarget's Volume 15 on February 5, 2024, entitled, "Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma."

8 Feb 2024

Enzyme released by immune cells may play role in depression

Mount Sinai researchers have shown for the first time that immune cells called monocytes, derived in the bone marrow and released into the bloodstream, can be drawn during stress into sites in the brain that control emotional behaviors.

8 Feb 2024

Study shows link between erectile dysfunction drugs and reduced risk of Alzheimer’s

The drugs used to treat erectile dysfunction may also be associated with a reduced risk of Alzheimer's disease, according to a study published in the February 7, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

7 Feb 2024

Reducing unnecessary testing or treatments in older patients

When a doctor ordered a routine prostate screening for an 80-year-old man - as doctors often do - a dramatic yellow alert popped up on the electronic health record with dire warnings.

7 Feb 2024

Study shines light on partial endothelial-to-mesenchymal transition in the tumor microenvironment

Endothelial-mesenchymal transition (EndoMT, also termed as EndMT), a biological process resulting in the formation of mesenchymal (or lineage-committed) phenotypes from endothelial cells (lining blood vessels), plays a crucial role in tumor progression.

7 Feb 2024

SPOC Proteomics announces new product launch at SLAS2024

SPOC Proteomics, Inc, a deep-tech life sciences company based out of Scottsdale Arizona (HQ) and Menlo Park California, announced the commercial launch of their customizable sensor-integrated proteome on chip (SPOC®) biosensors for limited beta testing at SLAS2024.

From SPOC Proteomics 7 Feb 2024

Drugs News and Research

States target health insurers’ ‘prior authorization’ red tape

Stress driving substance use in American teens, study finds

Drug repurposing study finds lonafarnib effective against RSV

New study finds 4’-fluorouridine effective against avian influenza in vitro and in vivo

IPIAD augments standard therapy for pancreatic ductal adenocarcinoma

Reducing diabetes medication costs can be one step toward improving health outcomes

Rucaparib and its major metabolite exhibit differential biological activity and synergy

LSHTM researchers receive £2m funding to develop novel vaccines, diagnostics and therapeutics

AI tool maps protein function in tumors, paving way for personalized cancer treatment

CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea

Men using erectile dysfunction drugs less likely to develop Alzheimer's disease

New MRI method enables early detection and better monitoring of multiple sclerosis

Immune cells in overdrive: Study finds unbalanced response worsens lung infections

New drug targets key mechanism in ALS, protects motor neurons

Hope for relapsed myeloma: Preclinical and clinical evidence for ruxolitinib's efficacy

Enzyme released by immune cells may play role in depression

Study shows link between erectile dysfunction drugs and reduced risk of Alzheimer’s

Reducing unnecessary testing or treatments in older patients

Study shines light on partial endothelial-to-mesenchymal transition in the tumor microenvironment

SPOC Proteomics announces new product launch at SLAS2024

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News